Kauvery Hospital, Alwarpet has successfully performed a highly complex and rare TAVR-in-TAVR-in-SAVR procedure with bioprosthetic valve fracture on a 78-year-old patient, marking one of the first such ...

Since it went on the market, the newer device has been the subject of several reports of hemolysis. This would seem counterintuitive given that hemolysis is thought to stem from the issue of ...

JP Morgan upgraded Edwards Lifesciences (EW) to overweight from neutral highlighting accelerating growth in its transcatheter aortic valve replacement (TAVR) division and strength in its transcatheter ...

The 7-year follow-up analysis included 496 patients who underwent transfemoral TAVR and 454 who underwent SAVR in the Placement of Aortic Transcatheter Valves (PARTNER) 3 trial and used the same ...

Low-risk patients with severe, symptomatic aortic stenosis show similar clinical outcomes and valve durability. HealthDay News — Seven-year follow-up data show that transcatheter aortic-valve ...

Background: Presumed valvular dysfunction following transcatheter aortic valve replacement (TAVR) is a recognized phenomenon that may lead to increased transvalvular gradients, and adverse ...

Following the ‘G’ and Gemini icons, Google is updating its logos for the AI era. Here’s a sneak peek at the new gradient icons for Google Photos and Maps. In May, the Google (Search) app got a new ...

CASE 2 – Aortic Stenosis and Mitral Stenosis – When and How to Treat? Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the ...

SAN FRANCISCO--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced seven-year data from the PARTNER 3 trial, reaffirming the early and sustained patient benefits of Edwards TAVR. The data ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...